{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:14:18Z","timestamp":1787494458572,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0531-5","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T07:55:03Z","timestamp":1508140503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults"],"prefix":"10.1186","volume":"16","author":[{"given":"Xiaoya","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2352-2031","authenticated-orcid":false,"given":"Yonghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"issue":"Suppl 4","key":"531_CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","volume":"28","author":"E Hashimoto","year":"2013","unstructured":"Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD\/NASH. J Gastroenterol Hepatol. 2013;28(Suppl 4):64\u201370.","journal-title":"J Gastroenterol Hepatol"},{"key":"531_CR2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"531_CR3","first-page":"129","volume":"58","author":"P Socha","year":"2007","unstructured":"Socha P, Wierzbicka A, Neuhoff-Murawska J, W\u0142odarek D, Podle\u015bny J, Socha J. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. Rocz Panstw Zakl Hig. 2007;58(1):129\u201337.","journal-title":"Rocz Panstw Zakl Hig"},{"key":"531_CR4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/BOR.0b013e32835d951e","volume":"25","author":"C Li","year":"2013","unstructured":"Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25:210\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"531_CR5","volume":"5","author":"C Xu","year":"2010","unstructured":"Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One. 2010;5:e11578.","journal-title":"PLoS One"},{"key":"531_CR6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.metabol.2010.08.005","volume":"60","author":"S Ryu","year":"2011","unstructured":"Ryu S, Chang Y, Kim SG, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism. 2011;60:860\u20136.","journal-title":"Metabolism"},{"key":"531_CR7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jhep.2008.11.021","volume":"50","author":"Y Li","year":"2009","unstructured":"Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol. 2009;50:1029\u201334.","journal-title":"J Hepatol"},{"key":"531_CR8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hep.23717","volume":"52","author":"A Afzali","year":"2010","unstructured":"Afzali A, Weiss NS, Boyko EJ, Ioannou GN. Association between serum uric acid level and chronic liver disease in the United States. Hepatology. 2010;52:578\u201389.","journal-title":"Hepatology"},{"key":"531_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000282084","volume":"28","author":"EE Powell","year":"2010","unstructured":"Powell EE, Jonsson JR, Clouston AD. Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Dig Dis. 2010;28:186\u201391.","journal-title":"Dig Dis"},{"key":"531_CR10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.metabol.2012.08.013","volume":"62","author":"JC Sirota","year":"2013","unstructured":"Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and nutrition examination survey. Metabolism. 2013;62:392\u20139.","journal-title":"Metabolism"},{"key":"531_CR11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","volume":"27","author":"CJ Liu","year":"2012","unstructured":"Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol. 2012;27:1555\u201360.","journal-title":"J Gastroenterol Hepatol"},{"key":"531_CR12","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","volume":"164","author":"HJ Kim","year":"2004","unstructured":"Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med. 2004;164:2169\u201375.","journal-title":"Arch Intern Med"},{"issue":"1","key":"531_CR13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.24013","volume":"53","author":"SM Martinez","year":"2011","unstructured":"Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53(1):325\u201335.","journal-title":"Hepatology"},{"key":"531_CR14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","volume":"9","author":"MD Zeng","year":"2008","unstructured":"Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis. 2008;9:108\u201312.","journal-title":"J Dig Dis"},{"key":"531_CR15","doi-asserted-by":"crossref","unstructured":"Xie Y, Wang M, Zhang Y, Zhang S, Tan A, Gao Y, Liang Z, Shi D, Huang Z, Zhang H, et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS One. 2013;8(7):e67152.","DOI":"10.1371\/journal.pone.0067152"},{"key":"531_CR16","doi-asserted-by":"publisher","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Adv Ther. 2017; doi: 10.1007\/s12325-017-0556-1 .","DOI":"10.1007\/s12325-017-0556-1"},{"key":"531_CR17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2188\/jea.JE20110120","volume":"22","author":"RN Feng","year":"2012","unstructured":"Feng RN, Zhao C, Wang C, Niu YC, Li K, Guo FC, Li ST, Sun CH, Li Y. BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults. J Epidemiol. 2012;22:317\u201323.","journal-title":"J Epidemiol"},{"issue":"2","key":"531_CR18","first-page":"305","volume":"19","author":"J Liang","year":"2015","unstructured":"Liang J, Pei Y, Gong Y, Liu XK, Dou LJ, Zou CY, Qiu QQ, Yang MQ, Qi L. Serum uric acid and non-alcoholic fatty liver disease in non-hypertensive Chinese adults: the Cardiometabolic risk in Chinese (CRC) study. Eur Rev Med Pharmacol Sci. 2015;19(2):305\u201311.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"531_CR19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcn\/86.2.353","volume":"86","author":"SA Lear","year":"2007","unstructured":"Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the multicultural community health assessment trial (M-CHAT). Am J Clin Nutr. 2007;86:353\u20139.","journal-title":"Am J Clin Nutr"},{"key":"531_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrgastro.2010.95","volume":"7","author":"NJ Wood","year":"2010","unstructured":"Wood NJ. Liver: nonobese individuals in the developing world are at risk of nonalcoholic fatty liver and liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:357.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"531_CR21","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","volume":"287","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287:40732\u201344.","journal-title":"J Biol Chem"},{"key":"531_CR22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","volume":"94","author":"YJ Choi","year":"2014","unstructured":"Choi YJ, Shin HS, Choi HS, Park JW, Jo I, Oh ES, Lee KY, Lee BH, Johnson RJ, Kang DH. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Investig. 2014;94:1114\u201325.","journal-title":"Lab Investig"},{"key":"531_CR23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.HYP.0000164570.20420.67","volume":"45","author":"Z Ackerman","year":"2005","unstructured":"Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, Sela BA. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension. 2005;45:1012\u20138.","journal-title":"Hypertension"},{"issue":"4","key":"531_CR24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","volume":"64","author":"X Wan","year":"2016","unstructured":"Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, He H, Liu X, Li Y, Yu C. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925\u201332.","journal-title":"J Hepatol"},{"issue":"10","key":"531_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047948","volume":"7","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, Li N, Roncal-Jimenez CA, Ishimoto T, Le M, Garcia GE, Thomas JB, Rivard CJ, et al. Uric acid stimulates fructokinase and accelerate fructose metabolism in the development of fatty liver. PLoS One. 2012;7(10):e47948.","journal-title":"PLoS One"},{"issue":"6","key":"531_CR26","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/hep.27356","volume":"60","author":"Q Gu","year":"2014","unstructured":"Gu Q, Yang X, Lin L, Li S, Li Q, Zhong S, Peng J, Cui Z. Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting. Hepatology. 2014;60(6):1929\u201341.","journal-title":"Hepatology"},{"issue":"11","key":"531_CR27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00535-011-0436-4","volume":"46","author":"M Yoneda","year":"2011","unstructured":"Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, et al. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. J Gastroenterol. 2011;46(11):1300\u20136.","journal-title":"J Gastroenterol"},{"issue":"2","key":"531_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1478-3231.2011.02639.x","volume":"32","author":"N Alkhouri","year":"2012","unstructured":"Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32(2):297\u2013302.","journal-title":"Liver Int"},{"issue":"9","key":"531_CR29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1440-1746.2006.04447.x","volume":"21","author":"H Kaneda","year":"2006","unstructured":"Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2006;21(9):1459\u201365.","journal-title":"J Gastroenterol Hepatol"},{"key":"531_CR30","doi-asserted-by":"crossref","unstructured":"Garjani A, Safaeiyan A, Khoshbaten M. Association between platelet count as a noninvasive marker and ultrasonographic grading in patients with nonalcoholic fatty liver disease. Hepat Mon. 2015;15(1):e24449.","DOI":"10.5812\/hepatmon.24449"},{"issue":"10","key":"531_CR31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/MEG.0000000000000405","volume":"27","author":"M Kara","year":"2015","unstructured":"Kara M, Dogru T, Genc H, Sertoglu E, Celebi G, Gurel H, Kayadibi H, Cicek AF, Ercin CN, Sonmez A. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27(10):1144\u20138.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T16:12:12Z","timestamp":1719504732000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0531-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0531-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]},"article-number":"202"}}